The University of Rochester says it’s working to take down hundreds of fake "wanted" posters found in buildings across the ...

Clinical update from ongoing MP0533 phase 1/2a dose escalation study confirms overall acceptable safety profile observed so far and initial ...

A poster campaign is creating awareness commemorating Edmonton-area soldiers who never came home. Joe MacDonald, the founder ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

Quince Therapeutics (QNCX) announced the poster presentation at the 53rd Child Neurology Society Annual Meeting of safety data from its prior Phase ... of B-cell lymphoma (unlikely treatment related) ...

A meme purports to outline what it calls "The Trump-Vance Project 2025 Plan," although both U.S. President-elect Trump and ...

FDA confirmed in a recent FDA Type B meeting under RMAT designation that the PROACT 1 Phase 3 study could be sufficient to support a full U.S. regulatory approval of rilparencel; ...

Here are three major benefits that are attracting users to this cutting-edge model. Reportedly, Haiku 3.5 can process 21,000 ...

Researchers provided recommendations for managing adverse events in patients with renal cell carcinoma receiving cabozantinib and nivolumab.